Elcatonin


Concise Prescribing Info
Special Precautions
Renal impairment; heart failure; child (short-term treatment only and monitor bone growth); lactation; skin test prior to administration.
Adverse Reactions
GI disturbances; tingling of the hands; skin rash; unpleasant taste; inflammatory reactions at Inj site; urinary frequency; tremor; transient hypocalcaemia (parenteral).
Drug Interactions
Cardiac glycosides.
Action
Description: Elcatonin, a synthetic analogue of eel calcitonin, inhibits osteoclastic bone resorption. It is used in the treatment of diseases characterized by high bone turnover eg, Paget's disease of bone and as an adjunct in the treatment of severe hypercalcaemia.
Disclaimer: This information is independently developed by MIMS based on Elcatonin from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in